Physician profile
Joseph M Anain
NPI 1235100041
$1,606.12
in general payments reported to CMS, 2019-2025
17 companies · $737 in 2025
The $737 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.04 · 2020: $137 · 2022: $364 · 2023: $309 · 2024: $40.33 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $178.09 | 2025 | Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $169.13 | 2023-2025 | Proclaim, Octrode |
| Innovation Technologies INC | $159.59 | 2023 | Irrisept |
| Smith+Nephew, INC. | $154.27 | 2025 | Memofix Super Elastic Nitinol Staple System, Digifuse Cannulated Intramedullary Fusion System |
| Integra Lifesciences Corporation | $149.99 | 2022 | |
| Lifenet Health | $143.73 | 2025 | Theragenesis Wound Matrix |
| Biocomposites INC | $113.87 | 2025 | Stimulan |
| Abbvie INC. | $110.60 | 2022 | |
| Okami Medical, INC. | $108.84 | 2023 | Lobo |
| Inari Medical, INC. | $108.68 | 2020 | |
| Baudax Bio INC. | $103.50 | 2022 | |
| Medtronic, INC. | $23.56 | 2024 | Venaseal |
| Pfizer INC. | $18.65 | 2023 | |
| Organogenesis INC. | $18.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.77 | 2024 | Eliquis |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $14.42 | 2020 | |
| Misonix INC | $14.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Anain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.